Figure 5个  Table 2个
    • Male (n = 31) Female (n = 25)
      Hospitalized time, d, M (P25-P75) 17 (14-21) 18 (11-20)
      Age, y, M (P25-P75) 40 (29-50) 41 (28-53)
      Travel history in Wuhan 5 (16.1) 2 (8.0)
      City
      Changchun 22 (71.0) 20 (80.0)
      Siping 9 (29.0) 5 (20.0)
      Age groups
      < 30 y 10 (32.2) 8 (32.0)
      30-49 y 13 (41.9) 10 (40.0)
      50-69 y 6 (19.4) 5 (20.0)
      ≥ 70 y 2 (6.5) 2 (8.0)
      Contact category
      Imported cases 15 (48.4) 9 (36.0)
      Primary cases 10 (32.2) 14 (56.0)
      Secondary cases 6 (19.4) 2 (8.0)
      Data are n (%) unless specified otherwise
      y: year; d: day

      Table 1.  The baseline characteristics of recovered cases with COVID-19.

    • Analytes Reference intervals Median (P25-P75) Increase (n%) Decrease (n%)
      Male Female
      Leukocyte parameters
        WBC, ×109/L 3.50-9.50 5.24 (3.98-6.30) 1/56 (1.8) 8/56 (14.3)
        NE, ×109/L 1.80-6.30 3.40 (2.58-4.38) 3/56 (5.4) 9/56 (16.1)
        LY, ×109/L 1.10-3.20 1.20 (0.90-1.66) 1/56 (1.8) 21/56 (37.5)
        EO, ×109/L 0.02-0.52 0.02 (0.00-0.04) 0/56 (0.0) 28/56 (50.0)
        BA, ×109/L 0.00-0.06 0.02 (0.00-0.03) 3/56 (5.4) 0/56 (0.0)
        MO, ×109/L 0.10-0.60 0.31 (0.25-0.50) 4/56 (7.1) 0/56 (0.0)
      Erythrocyte parameters
        RBC, ×1012/L 4.30-5.80 3.80-5.10 4.69 (4.29-5.09) 2/56 (3.6) 6/56 (10.7)
        HGB, g/L 130-175 115-150 145 (133-158) 2/56 (3.6) 2/56 (3.6)
        HCT, L/L 0.400-0.500 0.350-0.450 0.420 (0.386-0.446) 1/56 (1.8) 7/56 (12.5)
        MCV, fL 82.0-100.0 89.6 (86.6-92.3) 3/56 (5.4) 2/56 (3.6)
        MCH, pg 27.0-34.0 31.0 (30.0-31.9) 4/56 (7.1) 2/56 (3.6)
        MCHC, g/L 316-354 345 (341-349) 3/56 (5.4) 0/56 (0.0)
        RDW, % 11.00-16.00 11.60 (11.28-11.90) 0/56 (0.0) 6/56 (10.7)
      Platelet parameters
        PLT, ×109/L 125-350 202 (164-231) 4/56 (7.1) 7/56 (12.5)
        MPV, fL 6.5-12.0 9.4 (8.6-10.0) 0/56 (0.0) 0/56 (0.0)
        PDW, % 9.0-17.0 12.5 (10.9-14.2) 4/56 (7.1) 0/56 (0.0)
        PCT, % 0.108-0.282 0.180 (0.149-0.199) 5/56 (8.9) 3/56 (5.4)
      Coagulation parameters
        TT, s 14.0-20.0 15.6 (15.0-16.2) 0/35 (0.0) 0/35 (0.0)
        APTT, s 22.2-38.0 34.7(31.9-36.2) 4/35 (11.4) 0/35 (0.0)
        PT, s 11.0-13.0 11.9 (11.6-13.0) 9/35 (25.7) 2/35 (5.7)
        INR 0.90-1.30 1.07 (1.00-1.16) 3/35 (8.6) 1/35 (2.9)
        FBG, g/L 2.00-4.00 2.20 (2.01-3.13) 5/35 (14.3) 6/35 (17.1)
      Cardiac markers parameters
        hsCRP, mg/L < 6.0 6.0 (2.4-22.6) 21/43 (48.8) -
        Mb, ng/ml 0.0-61.5 22.7 (19.4-26.0) 0/30 (0.0) 0/30 (0.0)
        cTnI, ng/ml < 1.50 1.30 (1.10-1.80) 12/29 (41.4) -
        CK, U/L 50-310 40-200 76 (55-114) 3/47 (6.4) 5/47 (10.6)
        CK-MB, U/L 0.0-24.0 15.0 (11.5-22.0) 10/47 (21.3) 0/47 (0.0)
        LDH, L 120-250 207 (184-258) 13/47 (27.7) 0/47 (0.0)
        AST, U/L 15.0-40.0 13.0-35.0 25.0 (20.0-29.5) 6/47 (12.8) 1/47 (2.1)
      Liver function parameters
        ALT, U/L 9.0-50.0 7.0-40.0 25.0 (19.0-44.0) 11/47 (23.4) 0/47 (0.0)
        GGT, U/L 10.0-60.0 7.0-45.0 23.5 (15.0-39.5) 8/46 (17.4) 0/46 (0.0)
        CHE, U/L 5000-12000 8426 (6981-9023) 0/39 (0.0) 0/39 (0.0)
        TP, g/L 65.0-85.0 67.8 (65.3-71.7) 0/47 (0.0) 10/47 (21.3)
        ALB, g/L 40.0-55.0 44.1 (42.2-45.7) 0/47 (0.0) 4/47 (8.5)
        GLB, g/L 20.0-40.0 23.7 (21.7-26.7) 0/47 (0.0) 7/47 (14.9)
        TBIL, pmol/L < 23.0 7.9 (6.8-12.8) 1/47 (2.1) -
        DBIL, pmol/L < 8.0 3.6 (3.2-5.1) 1/47(2.1) -
        IBIL, pmol/L 5.10-21.40 4.40 (3.45-7.00) 0/47 (0.0) 27/47 (57.4)
      Kidney function parameters
        BUN, mmol/L 3.10-8.00 2.60-7.50 3.69 (3.08-4.70) 1/47 (2.1) 9/47 (19.1)
        Cr, pmol/L 57.0-97.0 41.0-73.0 68.0 (58.8-76.7) 2/47 (4.3) 2/47 (4.3)
        CO2-CP, mmol/L 22.0-29.0 20.7 (18.9-22.4) 0/47 (0.0) 32/47 (68.1)
        Glu, mol/L 3.89-6.11 6.04 (5.54-6.69) 23/47 (48.9) 0/47 (0.0)
      Electrolyte parameters
        K, mmol/L 3.50-5.30 4.08 (3.89-4.37) 1/48 (2.1) 2/48 (4.2)
        Na, mmol/L 137-147 138 (137-140) 0/48 (0.0) 12/48 (25.0)
        Cl, mmol/L 99-110 100 (98-102) 0/48 (0.0) 20/48 (41.7)
      WBC, White blood cell; NE, Neutrophil; LY, Lymphocyte; EO, Eosinophil; BA, Basophil; MO, Monocyte; RBC, Red blood cell; HGB, Hemoglobin; HCT, Hematocrit; MCV, Mean corpuscular volume; MCH, Mean corpuscular hemoglobin; MCHC, Mean corpuscular hemoglobin concentration; RDW, Red blood cell distribution width; PLT, Platelet count; MPV, Mean platelet volume; PDW, Platelet distribution width; PCT, Thrombocytocrit; TT, Thrombin time; APTT, Activated partial thromboplastin time; PT, Prothrombin time; INR, International normalized ratio; FBG, Fibrinogen; hsCRP, High-sensitivity C-reactive protein; Mb, Myoglobin; cTnI, Cardiac Troponin I; CK, Creatine kinase; CK-MB, Creatinine kinase-muscle/brain activity; LDH, Lactate dehydrogenase; AST, Aspartate aminotransferase; ALT, Alanine aminotransferase; GGT, γ-glutamyl transpeptidase; CHE, Cholinesterase; TP, Total protein; ALB, Albumin; GLB, Globulin; TBIL, Total bilirubin; DBIL, Direct bilirubin; IBIL, Indirect bilirubin; BUN, Blood urea nitrogen; Cr, Creatinine; CO2-CP, Carbon dioxide combining power; Glu, Glucose; K, Potassium; Na, Sodium; Cl, Chloride

      Table 2.  Laboratory findings of patients with COVID-19 at onset to hospital admission.